fbpx
Bausch + Lomb

B + L and GRF Announce Launch of Screen, Protect, Cure Campaign in Recognition of Glaucoma Awareness Month

Bausch + Lomb and Glaucoma Research Foundation (GRF), a national non-profit organization with the vision of curing glaucoma, announced the U.S. launch of ‘Screen, Protect, Cure,’ a campaign designed to provide educational resources and raise awareness of glaucoma, a leading cause of irreversible blindness, during Glaucoma Awareness Month.

“We are proud to collaborate with Glaucoma Research Foundation to provide critical information about this serious eye disease and underline the negative toll it can have if left untreated,” said Christina Ackermann, president, Ophthalmic Pharmaceuticals, Bausch + Lomb. “Glaucoma can affect individuals of all ages and only half of those affected are aware they have it, so it’s important that we share risk factors, how to get tested and what treatment options are available. Through ‘Screen, Protect, Cure,’ we hope to help support patients in every step of their treatment journey.”

During the month of January, Glaucoma Awareness Month, Bausch + Lomb and GRF will share educational resources to educate individuals who may be at risk for glaucoma and empower them to take an informed and active role in their eye health. The campaign also features a fundraising challenge that will match every dollar raised up to $20,000 in support of GRF research for a potential cure for glaucoma.

“Glaucoma Awareness Month provides a great opportunity to share information about this sight-threatening disease and remind people there are steps they can take to help preserve their vision,” said Thomas M. Brunner, president & CEO, GRF. “Visiting an eye care provider on an annual basis and paying attention to visual function are the best things someone can do to avoid the irreversible damage from glaucoma. Although there is currently no cure, our fight to prevent visual disability is ongoing, and we are grateful for the collaboration of organizations, such as Bausch + Lomb, who share this commitment with us.”

Learn more at glaucoma.org/screen-protect-cure.

Click HERE for the full press release.

Featured Posts

Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read More
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read More
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read More
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read More
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more
Managing anxious children optometry pre-testing

Pivot to Patience: Managing the Emotionally Elevated Child in Pre-Testing

Discover 5 EQ-based strategies for managing an anxious or emotionally elevated child during optometry pre-testing in 2026. Learn how to de-escalate and ensure accurate clinical data.

Learn More
Voila July-August Optik 2026 Centennial DILLI DALLI 7111

Dilli Dalli – Now Available in Canda

Now available in Canada, Dilli Dalli offers fit-focused eyewear for infants, toddlers and children, with SoftTouch, TR-90 and lightweight metal options designed to support pediatric dispensing.

Read more
AYA Optical logo and Carla DAngelo photo 2026

AYA Optical: Where Art Meets Eyewear

AYA Optical brings together Indigenous art and contemporary eyewear design, creating frames that honour artists while offering a distinctive and meaningful visual identity.

Read more
The Vision Council Foundation logo

The Vision Council Foundation Expands “See What Matters” with New Back‑to‑School Eye Health Toolkit

The Vision Council Foundation has expanded its See What Matters initiative with new back to school toolkits focused on childhood myopia, digital eye strain and the importance of annual eye exams.

Read more
Bausch + Lomb

Bausch + Lomb Advances Two First‑in‑Class Eye Health Therapies Following New Clinical Results

Bausch + Lomb is advancing two first in class therapies following new clinical results, including a Phase 3 dry eye combination treatment and a TRPV1 antagonist showing early pain reduction.

Read more